In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-13 of 13 for your search:
Drug:  chlorambucil
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MO22468, 2009-012072-28, NCT01056510

2.

Phase: Phase III
Type: Treatment
Status: Unknown
Age: 18 and over
Sponsor: Other
Protocol IDs: TSH-WM1, ISRCTN56052618, TSH-WM1, NCT00608374

3.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: OMB110911, NCT00748189

4.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 65 and ovr
Sponsor: Pharmaceutical / Industry
Protocol IDs: CC-5013-CLL-008, 2008-003079-32, NCT00910910

5.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: BO21004 (Stage 1a), 2009-012476-28; CLL11, NCT01010061

6.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 65 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PCYC-1115-CA, 2012-003967-23, NCT01722487

7.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MO20927, NCT00532129

8.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 65 to 80
Sponsor: Other
Protocol IDs: CDR0000589544, GOELAMS-MANTEAU-2006-SA, INCA-RECF0475, MANTEAU 2006 SA, EUDRACT-2006-004768-30, NCT00740415

9.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 60 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ML21445, 2008-001612-20, NCT00738374

10.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CC-5013-MCL-002, NCT00875667

11.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: SIM-79-001, NCT01109264

12.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 115601, NCT01563055

13.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 116586, NCT01808326
New Search